CYTL1

cytokine like 1

Basic information

Region (hg38): 4:5014586-5019458

Links

ENSG00000170891NCBI:54360OMIM:607930HGNC:24435Uniprot:Q9NRR1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CYTL1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYTL1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
9
clinvar
1
clinvar
10
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 9 1 0

Variants in CYTL1

This is a list of pathogenic ClinVar variants found in the CYTL1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-5015155-C-T not specified Uncertain significance (May 25, 2022)2351747
4-5015161-C-T not specified Likely benign (Aug 10, 2023)2617816
4-5015162-G-C not specified Uncertain significance (Nov 09, 2022)2258572
4-5015167-G-C not specified Uncertain significance (Jun 02, 2023)2556149
4-5015176-G-A not specified Uncertain significance (Dec 16, 2023)3079831
4-5015231-A-C not specified Uncertain significance (Jan 27, 2022)2274336
4-5016884-C-G not specified Uncertain significance (Apr 09, 2024)3270742
4-5016898-C-T not specified Uncertain significance (Feb 28, 2024)3079830
4-5016918-G-A not specified Uncertain significance (Sep 27, 2021)2358222
4-5016933-A-G not specified Uncertain significance (Nov 23, 2022)2205543
4-5019301-C-G not specified Uncertain significance (Oct 04, 2022)2316908
4-5019304-A-G not specified Uncertain significance (Mar 15, 2024)3270744
4-5019393-G-C not specified Uncertain significance (Apr 12, 2024)3270743

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CYTL1protein_codingprotein_codingENST00000307746 44887
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00001070.2081257160321257480.000127
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1136971.70.9620.00000405842
Missense in Polyphen2323.3450.98523305
Synonymous0.5372932.90.8810.00000176293
Loss of Function-0.37176.021.163.53e-767

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006150.0000615
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00009240.0000924
European (Non-Finnish)0.0002210.000220
Middle Eastern0.000.00
South Asian0.0001310.000131
Other0.000.00

dbNSFP

Source: dbNSFP

Pathway
TYROBP Causal Network (Consensus)

Recessive Scores

pRec
0.173

Intolerance Scores

loftool
rvis_EVS
0.26
rvis_percentile_EVS
70.06

Haploinsufficiency Scores

pHI
0.333
hipred
N
hipred_score
0.198
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.132

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cytl1
Phenotype
skeleton phenotype; immune system phenotype;

Gene ontology

Biological process
chondrocyte differentiation;signal transduction;positive regulation of transcription by RNA polymerase II;inner ear development;chondroitin sulfate proteoglycan biosynthetic process;positive regulation of DNA-binding transcription factor activity;cartilage homeostasis
Cellular component
extracellular space
Molecular function
signaling receptor binding